© 2000 American Heart Association, Inc.
Vascular Biology |
Cytokines Induce Upregulation of Vascular P2Y2 Receptors and Increased Mitogenic Responses to UTP and ATP
From the Division of Experimental Vascular Research, Department of Medicine, Lund University Hospital, Lund, Sweden.
Correspondence to Dr David Erlinge, Department of Cardiology, Lund University Hospital, S-221 85 Lund, Sweden. E-mail david.erlinge{at}med.lu.se
Abstract—P2Y2
receptors, which mediate contractile and mitogenic effects
of extracellular nucleotides in vascular smooth muscle
cells (VSMCs), are upregulated in the synthetic phenotype of
VSMCs and in the neointima after balloon angioplasty,
suggesting a role in the development of
atherosclerosis. Because released cytokines in
atherosclerotic lesions mediate multiple effects on gene transcription
in VSMCs, we speculated that cytokines could be involved in the
regulation of P2Y2 receptor expression. Using a competitive
reverse transcription–polymerase chain reaction, we detected that
interleukin (IL)-1ß induced a time- and dose-dependent upregulation
of P2Y2 receptor mRNA, which was dramatically enhanced when
combined with interferon-
or tumor necrosis factor-
.
Lipopolysaccharide also significantly increased the expression
of P2Y2 receptor mRNA. The upregulation of P2Y2
receptor mRNA was paralleled at the functional level because
IL-1ß significantly increased the UTP-stimulated DNA synthesis and
the release of intracellular Ca2+. Actinomycin D completely
blocked the upregulation of P2Y2 receptor mRNA expression
by IL-1ß, indicating de novo mRNA synthesis. There was no cAMP
accumulation in the cells stimulated with IL-1ß. The
cyclooxygenase inhibitor
indomethacin and the protein kinase C
inhibitor RO-31-8220 inhibited IL-1ß–induced
upregulation of P2Y2 receptor mRNA expression, whereas
rapamycin and PD098059 had no effects. Furthermore, neither P38
mitogen-activated protein kinase inhibitor SB20358
alone nor its combination with PD098059 blocked the effect of IL-1ß
on the expression of P2Y2 receptor mRNA. Our results
demonstrate that inflammatory mediators upregulate vascular
P2Y2 receptors at the transcriptional and at the functional
level through protein kinase C and cyclooxygenase
but not cAMP, extracellular signal–regulated kinases 1 and 2, or
P38-dependent pathways. This may result in increased growth-stimulatory
or contractile effects of extracellular UTP and ATP, which may be of
importance in the development of vascular disease.
Key Words: P2Y2 receptors • interleukin-1ß • competitive reverse transcription–polymerase chain reaction
This article has been cited by other articles:
 |
|
 |
|
  D. M. Grbic, E. Degagne, C. Langlois, A.-A. Dupuis, and F.-P. Gendron Intestinal Inflammation Increases the Expression of the P2Y6 Receptor on Epithelial Cells and the Release of CXC Chemokine Ligand 8 by UDP J. Immunol., February 15, 2008; 180(4): 2659 - 2668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Burnstock Physiology and Pathophysiology of Purinergic Neurotransmission Physiol Rev, April 1, 2007; 87(2): 659 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Abbracchio, G. Burnstock, J.-M. Boeynaems, E. A. Barnard, J. L. Boyer, C. Kennedy, G. E. Knight, M. Fumagalli, C. Gachet, K. A. Jacobson, et al. International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy Pharmacol. Rev., September 1, 2006; 58(3): 281 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. P. Robinson III, C. D. Douillet, P. M. Milano, R. C. Boucher, C. Patterson, and P. B. Rich ATP stimulates MMP-2 release from human aortic smooth muscle cells via JNK signaling pathway Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1988 - H1996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Coutinho-Silva, L. Stahl, K.-K. Cheung, N. E. de Campos, C. de Oliveira Souza, D. M. Ojcius, and G. Burnstock P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G1024 - G1035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Furukoji, M. Matsumoto, A. Yamashita, H. Yagi, Y. Sakurai, K. Marutsuka, K. Hatakeyama, K. Morishita, Y. Fujimura, S. Tamura, et al. Adenovirus-Mediated Transfer of Human Placental Ectonucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation In Vitro and Arterial Thrombus Formation In Vivo Circulation, February 15, 2005; 111(6): 808 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Vonend, T. Apel, K. Amann, L. Sellin, J. Stegbauer, E. Ritz, and L. C. Rump Modulation of gene expression by moxonidine in rats with chronic renal failure Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2217 - 2222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Erlinge Extracellular ATP: a central player in the regulation of vascular smooth muscle phenotype. Focus on "Dual role of PKA in phenotype modulation of vascular smooth muscle cells by extracellular ATP" Am J Physiol Cell Physiol, August 1, 2004; 287(2): C260 - C262. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Schafer, F. Sedehizade, T. Welte, and G. Reiser ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L376 - L385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Berenbaum, L. Humbert, G. Bereziat, and S. Thirion Concomitant Recruitment of ERK1/2 and p38 MAPK Signalling Pathway Is Required for Activation of Cytoplasmic Phospholipase A2 via ATP in Articular Chondrocytes J. Biol. Chem., April 11, 2003; 278(16): 13680 - 13687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Leipziger Control of epithelial transport via luminal P2 receptors Am J Physiol Renal Physiol, March 1, 2003; 284(3): F419 - F432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. T. Gerthoffer and C. A. Singer Secretory Functions of Smooth Muscle: Cytokines and Growth Factors Mol. Interv., November 1, 2002; 2(7): 447 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Sergeant, R. J. Large, E. A. H. Beckett, C. M. McGeough, S. M. Ward, and B. Horowitz Microarray comparison of normal and W/Wv mice in the gastric fundus indicates a supersensitive phenotype Physiol Genomics, October 2, 2002; 11(1): 1 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Sevigny, C. Sundberg, N. Braun, O. Guckelberger, E. Csizmadia, I. Qawi, M. Imai, H. Zimmermann, and S. C. Robson Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation Blood, April 15, 2002; 99(8): 2801 - 2809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Burnstock Purinergic Signaling and Vascular Cell Proliferation and Death Arterioscler Thromb Vasc Biol, March 1, 2002; 22(3): 364 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hou, T. K. Harden, C. M. Kuhn, B. Baldetorp, E. Lazarowski, W. Pendergast, S. Moller, L. Edvinsson, and D. Erlinge UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y6 receptors Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H784 - H792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chaulet, C. Desgranges, M.-A. Renault, F. Dupuch, G. Ezan, F. Peiretti, G. Loirand, P. Pacaud, and A.-P. Gadeau Extracellular Nucleotides Induce Arterial Smooth Muscle Cell Migration Via Osteopontin Circ. Res., October 26, 2001; 89(9): 772 - 778. [Abstract] [Full Text] [PDF]
|
|